Patricia McDonald

Title: Patricia McDonald: Innovator in GPCR Agonist Polypeptides

Introduction

Patricia McDonald is a notable inventor based in Jupiter, FL (US). She has made significant contributions to the field of biochemistry, particularly in the development of methods and compositions related to GPCR agonist polypeptides. Her work has implications for treating various diseases, including diabetes and obesity.

Latest Patents

Patricia McDonald holds 1 patent for her invention titled "Methods and compositions related to GPCR agonist polypeptides." This invention provides combinatorial peptide or polypeptide libraries that can become membrane tethered once expressed in cells. Additionally, it offers methods for selecting peptide modulators, such as agonists, of GPCRs from these combinatorial libraries. The invention also introduces novel GPCR polypeptide modulators, including biased polypeptide agonists of the glucagon-like peptide 1 receptor (GLP-1R). Furthermore, it outlines methods for promoting insulin sensitivity, lowering blood glucose, and reducing body weight.

Career Highlights

Patricia McDonald is affiliated with the Scripps Research Institute, where she continues her research and innovation in the field of biochemistry. Her work has garnered attention for its potential to impact health and wellness significantly.

Collaborations

Some of her notable coworkers include Jia Xie and Richard A. Lerner, who have collaborated with her on various research projects.

Conclusion

Patricia McDonald is a pioneering inventor whose work in GPCR agonist polypeptides holds promise for advancing treatments for diabetes and obesity. Her contributions to the field are invaluable and continue to inspire future innovations.